Adipose-derived Mesenchymal Stem Cell (Qilu Cell Therapy)

脂肪间充质干细胞（齐鲁细胞）

Report date: 2025/04/02 13:36:21

Base Information

Drug NameAdipose-derived Mesenchymal Stem Cell (Qilu Cell Therapy)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, KneeCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
Inactive CompaniesQilu Hospital Of Shandong University
Active IndicationsCartilage Diseases
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A